Skip to main contentSkip to navigation
Sirius Investors
Interpace Biosciences, Inc.

Interpace Biosciences, Inc.

IDXG
OTCHealthcare

IDXG Financial Statements & Analysis

Complete financial statements for IDXG including income statement, balance sheet, and cash flow statement. Analyze IDXG's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
-6.4%
Net Income
-3.8%
Gross Margin
0.4%
Operating Margin
-11.6%

Balance Sheet

Current Ratio
29.6%
Debt to Equity
-11.6%
Asset Turnover
-5.2%

Cash Flow

Operating Cash Flow
-16.3%
Net Cash Flow
39.0%
Free Cash Flow
-20.0%
Cash Flow to Debt
-8.3%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q4 '25TTM Q1 '26ChangeImpact
Revenue38.73M36.24M6.4%
Gross Profit24.13M22.66M6.1%
Operating Income4.08M3.38M17.3%
Net Income24.57M23.65M3.8%
EPS1.390.6652.8%
EBITDA4.76M4.07M14.5%
Gross Margin62.31%62.53%0.4%
Operating Margin10.55%9.32%11.6%
Net Income Margin63.46%65.25%2.8%
R&D Expenses642.00K618.00K3.7%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Revenue36.24M38.73M41.82M
Gross Profit22.66M24.13M27.00M
Operating Income3.38M4.08M5.58M
Net Income23.65M24.57M4.81M
EPS0.661.390.27
EBITDA4.07M4.76M6.06M
Gross Margin62.53%62.31%64.57%
Operating Margin9.32%10.55%13.34%
Net Income Margin65.25%63.46%11.50%
R&D Expenses618.00K642.00K693.00K

Our detailed financial analysis helps investors understand IDXG's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track IDXG's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into IDXG's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
Interpace Biosciences, Inc. (IDXG) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors